It was reported that insulin treatment restores tau phosphorylation to physiological levels in streptozotocin-treated C57BL/6NJcl adult mice [59], whereas the effect of insulin on rescuing tau pathology in AD models has yet to be documented. The gene discussed is MAPT; the disease is Alzheimer disease.